BIBLF yields 3.08% · JNJ yields 2.13%● Live data
📍 BIBLF pulled ahead of the other in Year 1
Combined, BIBLF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BIBLF + JNJ for your $10,000?
Waterloo Brewing Ltd. engages in the production, distribution, and sale of alcohol-based products. It produces, sells, markets, and distributes bottled, canned, and draft premium beer under the Waterloo brand name; and value beer under the Laker and Red Cap brands. The company also produces, sells, and markets vodka-based coolers and ciders under the Seagram trademark; beer under the LandShark brand name; and coolers under the Margaritaville trademark. In addition, it produces, sells, markets, and distributes various beer products under the licensed PC trademark; and produces various products under the No Name brand. Further, the company engages in producing and packaging beer and ready-to-drink alcoholic beverages for other customers. It distributes products to end consumers primarily through grocery stores, The Beer Store in Ontario, and Provincial Liquor Boards in Canada. The company was formerly known as Brick Brewing Co. Limited and changed its name to Waterloo Brewing Ltd. in June 2019. Waterloo Brewing Ltd. was incorporated in 1984 and is headquartered in Kitchener, Ontario.
Full BIBLF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.